United States Healthcare Equipment & Supplies

Becton Dickinson and Co (BDX)

Track

Becton Dickinson executives offloaded over 1.3 million dollars in stock during the past quarter. These seventeen transactions, exclusively sales, occurred as the share price reached near-record highs. Following a positive earnings report, leadership activity reflects consistent divestment patterns rather than acquisitions, aligning with the company's strong recent market performance of 27.7 percent.
Ticker: BDX Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Becton Dickinson and Co. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Polen Thomas E Jr Chairman, CEO and President Executive Director
Transaction date
Sale
Price
408.02
Quantity 42,978 -35.1%
Value US$4,408,338
THOMAS POLEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
131.90
Quantity 25,249
Value US$3,963,645
2.8
Goette Roland EVP and President, EMEA Officer
Transaction date
Sale
Price
278.20
Quantity 31,303 -31.0%
Value US$3,479,856
2.8
Roland Goette Officer Officer
Transaction date
Proposed sale
Price
180.84
Quantity 1,000
Value US$100,000
3.1
SHANA NEAL Officer Officer
Transaction date
Proposed sale
Price
165.62
Quantity 1,000
Value US$100,000
2.8
Feld Michael EVP, Chief Revenue Officer Officer
Transaction date
Sale
Price
157.13
Quantity 1,000 -0.4%
Value US$100,000
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
156.36
Quantity 1,000
Value US$100,000
2.8
Feld Michael EVP, Chief Revenue Officer Officer
Transaction date
Sale
Price
152.80
Quantity 75 -0.4%
Value US$11,460
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
151.38
Quantity 75
Value US$11,354
3.1
Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer
Transaction date
Sale
Price
145.66
Quantity 1,100 -7.7%
Value US$160,226
3.1
MICHAEL GARRISON Officer Officer
Transaction date
Proposed sale
Price
143.92
Quantity 1,100
Value US$158,312
3.1
Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer
Transaction date
Sale
Price
151.48
Quantity 1,100 -7.2%
Value US$166,628
3.1
Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer
Transaction date
Sale
Price
151.48
Quantity 1,100 -7.2%
Value US$166,628
3.1
MICHAEL GARRISON Officer Officer
Transaction date
Proposed sale
Price
152.04
Quantity 1,100
Value US$167,244
Polen Thomas E Jr Chairman, CEO and President Executive Director
Transaction date
Sale
Price
146.35
Quantity 2,764 -2.4%
Value US$404,511
THOMAS POLEN Officer Officer
Transaction date
Proposed sale
Price
147.12
Quantity 2,764
Value US$406,640
2.8
Feld Michael EVP, Chief Revenue Officer Officer
Transaction date
Sale
Price
147.35
Quantity 75 -0.4%
Value US$11,051
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
147.63
Quantity 75
Value US$11,072
2.8
Feld Michael EVP, Chief Revenue Officer Officer
Transaction date
Sale
Price
151.94
Quantity 74 -0.3%
Value US$11,244
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
152.14
Quantity 74
Value US$11,258
2.8
Feld Michael EVP, Chief Revenue Officer Officer
Transaction date
Planned sale
Price
156.83
Quantity 75 -0.4%
Value US$11,762
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
158.27
Quantity 75
Value US$11,870
2.8
Feld Michael EVP, Chief Revenue Officer Officer
Transaction date
Sale
Price
181.84
Quantity 75 -0.4%
Value US$13,638
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
180.96
Quantity 75
Value US$13,572
2.4
DAVID MICHEL SHAN Former Officer Officer
Transaction date
Proposed sale
Price
184.14
Quantity 5,422
Value US$998,429
CHRISTOPHER DELOREFICE Former Officer Officer
Transaction date
Proposed sale
Price
183.91
Quantity 11,305
Value US$2,079,070
3.0
SCOTT BERTRAM L Non-Executive Director
Transaction date
Sale
Price
182.61
Quantity 953 -2.5%
Value US$174,027
CHRISTOPHER DELOREFICE Former Officer Officer
Transaction date
Proposed sale
Price
182.46
Quantity 9,366
Value US$1,708,886
3.0
BERTRAM SCOTT Director Non-Executive Director
Transaction date
Proposed sale
Price
182.61
Quantity 953
Value US$174,027
2.8
Feld Michael EVP, CRO & Pres. Life Sciences Officer
Transaction date
Sale
Price
202.73
Quantity 75 -0.5%
Value US$15,205
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
201.79
Quantity 75
Value US$15,134
3.1
Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer
Transaction date
Sale
Price
206.54
Quantity 1,010 -7.7%
Value US$208,605
3.1
Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer
Transaction date
Sale
Price
209.00
Quantity 600 -4.4%
Value US$125,400
3.1
MICHAEL GARRISON Officer Officer
Transaction date
Proposed sale
Price
207.42
Quantity 1,610
Value US$333,946
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
196.12
Quantity 74
Value US$14,513
2.8
Feld Michael EVP, CRO & Pres. Life Sciences Officer
Transaction date
Sale
Price
196.08
Quantity 74 -0.4%
Value US$14,510
3.1
MICHAEL GARRISON Officer Officer
Transaction date
Proposed sale
Price
196.39
Quantity 629
Value US$123,529
3.1
Garrison Michael David EVP & Pres Med.Essntl&BioPharm Officer
Transaction date
Sale
Price
196.03
Quantity 629 -4.6%
Value US$123,303
2.8
Feld Michael EVP, CRO & Pres. Life Sciences Officer
Transaction date
Sale
Price
193.36
Quantity 75 -0.5%
Value US$14,502
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
194.02
Quantity 75
Value US$14,552
3.0
BERTRAM SCOTT Officer Officer
Transaction date
Proposed sale
Price
176.58
Quantity 217
Value US$38,318
3.0
SCOTT BERTRAM L Non-Executive Director
Transaction date
Sale
Price
176.58
Quantity 217 -0.6%
Value US$38,318
2.8
Feld Michael EVP & President, Life Sciences Officer
Transaction date
Sale
Price
186.01
Quantity 57 -0.7%
Value US$10,603
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
185.83
Quantity 57
Value US$10,592
2.8
Feld Michael EVP & President, Life Sciences Officer
Transaction date
Sale
Price
181.03
Quantity 58 -0.7%
Value US$10,500
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
180.59
Quantity 58
Value US$10,474
3.5
Fraser Claire Non-Executive Director
Transaction date
Sale
Price
187.50
Quantity 917 -4.0%
Value US$171,938
3.5
Fraser Claire Director Non-Executive Director
Transaction date
Proposed sale
Price
187.42
Quantity 917
Value US$171,862
2.8
Feld Michael EVP & President, Life Sciences Officer
Transaction date
Sale
Price
197.99
Quantity 57 -0.7%
Value US$11,285
2.8
MICHAEL FELD Officer Officer
Transaction date
Proposed sale
Price
196.63
Quantity 57
Value US$11,208
3.5
HAYES GREGORY Non-Executive Director
Transaction date
Purchase
Price
191.57
Quantity 5,250 +659.5%
Value US$1,005,742
3.5
Fraser Claire Director Non-Executive Director
Transaction date
Proposed sale
Price
192.21
Quantity 863
Value US$165,880
3.5
Fraser Claire Non-Executive Director
Transaction date
Sale
Price
192.30
Quantity 863 -3.6%
Value US$165,955
3.1
Garrison Michael David EVP & President, Medical Officer
Transaction date
Sale
Price
181.50
Quantity 1 -0.0%
Value US$182
3.1
Garrison Michael David EVP & President, Medical Officer
Transaction date
Sale
Price
180.29
Quantity 1,184 -19.5%
Value US$213,463
3.1
MICHAEL GARRISON Officer Officer
Transaction date
Proposed sale
Price
180.90
Quantity 1,185
Value US$214,366
2.4
DAVID SHAN Officer Officer
Transaction date
Proposed sale
Price
172.59
Quantity 1,166
Value US$201,240
2.4
Shan David EVP and Chief ISC Officer Officer
Transaction date
Sale
Price
171.19
Quantity 1,166 -20.3%
Value US$199,608
3.1
Garrison Michael David EVP & President, Medical Officer
Transaction date
Sale
Price
197.28
Quantity 479 -8.9%
Value US$94,497
3.1
MICHAEL GARRISON Officer Officer
Transaction date
Proposed sale
Price
200.83
Quantity 479
Value US$96,198
3.2
Byrd Richard EVP & President Interventional Officer
Transaction date
Sale
Price
230.00
Quantity 459 -6.2%
Value US$105,570
3.2
RICHARD BYRD Officer Officer
Transaction date
Proposed sale
Price
227.83
Quantity 459
Value US$104,574
3.2
Byrd Richard EVP & President Interventional Officer
Transaction date
Sale
Price
224.91
Quantity 1,940 -20.7%
Value US$436,325
3.2
RICHARD BYRD Officer Officer
Transaction date
Proposed sale
Price
224.92
Quantity 1,940
Value US$436,345
3.0
BERTRAM SCOTT Director Non-Executive Director
Transaction date
Proposed sale
Price
227.99
Quantity 700
Value US$159,593
3.0
SCOTT BERTRAM L Non-Executive Director
Transaction date
Sale
Price
227.99
Quantity 700 -1.9%
Value US$159,593
2.9
Henderson Jeffrey William Non-Executive Director
Transaction date
Purchase
Price
233.62
Quantity 1,500 +23.0%
Value US$350,430
3.1
Neal Shana Carol EVP and Chief People Officer Officer
Transaction date
Sale
Price
240.00
Quantity 787 -4.9%
Value US$188,880
2.4
Shan David EVP and Chief ISC Officer Officer
Transaction date
Sale
Price
240.00
Quantity 500 -8.0%
Value US$120,000
3.1
SHANA NEAL Officer Officer
Transaction date
Proposed sale
Price
237.38
Quantity 787
Value US$186,818
2.4
DAVID SHAN Officer Officer
Transaction date
Proposed sale
Price
237.38
Quantity 500
Value US$118,690
3.1
Garrison Michael David EVP & President, Medical Officer
Transaction date
Sale
Price
236.51
Quantity 597 -9.7%
Value US$141,196
3.1
MICHAEL GARRISON Officer Officer
Transaction date
Proposed sale
Price
236.30
Quantity 597
Value US$141,071
3.1
Neal Shana Carol EVP and Chief People Officer Officer
Transaction date
Sale
Price
235.00
Quantity 788 -4.6%
Value US$185,180
3.1
SHANA NEAL Officer Officer
Transaction date
Proposed sale
Price
230.70
Quantity 788
Value US$181,792
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-14 2026-08-13 S Sale
Polen Thomas E Jr

Chairman, CEO and President

Executive Director
42,978 -35.1%
408.02
US$4,408,338 		42,978 -35.1% 408.02 US$4,408,338
2026-08-13 2026-08-13 PrS Proposed sale
THOMAS POLEN

Director; Officer

Executive Director
25,249
131.90
US$3,963,645 		25,249 131.90 US$3,963,645
2026-08-12 2026-08-11 S Sale
2.8
Goette Roland

EVP and President, EMEA

Officer
31,303 -31.0%
278.20
US$3,479,856 		31,303 -31.0% 278.20 US$3,479,856
2026-08-11 2026-08-11 PrS Proposed sale
2.8
Roland Goette

Officer

Officer
1,000
180.84
US$100,000 		1,000 180.84 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
3.1
SHANA NEAL

Officer

Officer
1,000
165.62
US$100,000 		1,000 165.62 US$100,000
2026-07-28 2026-07-27 S Sale
2.8
Feld Michael

EVP, Chief Revenue Officer

Officer
1,000 -0.4%
157.13
US$100,000 		1,000 -0.4% 157.13 US$100,000
2026-07-27 2026-07-27 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
1,000
156.36
US$100,000 		1,000 156.36 US$100,000
2026-06-26 2026-06-26 S Sale
2.8
Feld Michael

EVP, Chief Revenue Officer

Officer
75 -0.4%
152.80
US$11,460 		75 -0.4% 152.80 US$11,460
2026-06-26 2026-06-26 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
75
151.38
US$11,354 		75 151.38 US$11,354
2026-06-25 2026-06-24 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
1,100 -7.7%
145.66
US$160,226 		1,100 -7.7% 145.66 US$160,226
2026-06-24 2026-06-24 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
1,100
143.92
US$158,312 		1,100 143.92 US$158,312
2026-06-11 2026-06-10 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
1,100 -7.2%
151.48
US$166,628 		1,100 -7.2% 151.48 US$166,628
2026-06-11 2026-06-10 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
1,100 -7.2%
151.48
US$166,628 		1,100 -7.2% 151.48 US$166,628
2026-06-10 2026-06-10 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
1,100
152.04
US$167,244 		1,100 152.04 US$167,244
2026-06-03 2026-06-01 S Sale
Polen Thomas E Jr

Chairman, CEO and President

Executive Director
2,764 -2.4%
146.35
US$404,511 		2,764 -2.4% 146.35 US$404,511
2026-06-01 2026-06-01 PrS Proposed sale
THOMAS POLEN

Officer

Officer
2,764
147.12
US$406,640 		2,764 147.12 US$406,640
2026-05-27 2026-05-26 S Sale
2.8
Feld Michael

EVP, Chief Revenue Officer

Officer
75 -0.4%
147.35
US$11,051 		75 -0.4% 147.35 US$11,051
2026-05-26 2026-05-26 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
75
147.63
US$11,072 		75 147.63 US$11,072
2026-04-28 2026-04-27 S Sale
2.8
Feld Michael

EVP, Chief Revenue Officer

Officer
74 -0.3%
151.94
US$11,244 		74 -0.3% 151.94 US$11,244
2026-04-27 2026-04-27 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
74
152.14
US$11,258 		74 152.14 US$11,258
2026-03-27 2026-03-26 PlS Planned sale
2.8
Feld Michael

EVP, Chief Revenue Officer

Officer
75 -0.4%
156.83
US$11,762 		75 -0.4% 156.83 US$11,762
2026-03-26 2026-03-26 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
75
158.27
US$11,870 		75 158.27 US$11,870
2026-02-27 2026-02-26 S Sale
2.8
Feld Michael

EVP, Chief Revenue Officer

Officer
75 -0.4%
181.84
US$13,638 		75 -0.4% 181.84 US$13,638
2026-02-26 2026-02-26 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
75
180.96
US$13,572 		75 180.96 US$13,572
2026-02-20 2026-02-20 PrS Proposed sale
2.4
DAVID MICHEL SHAN

Former Officer

Officer
5,422
184.14
US$998,429 		5,422 184.14 US$998,429
2026-02-20 2026-02-20 PrS Proposed sale
CHRISTOPHER DELOREFICE

Former Officer

Officer
11,305
183.91
US$2,079,070 		11,305 183.91 US$2,079,070
2026-02-18 2026-02-18 S Sale
3.0
SCOTT BERTRAM L
Non-Executive Director
953 -2.5%
182.61
US$174,027 		953 -2.5% 182.61 US$174,027
2026-02-18 2026-02-18 PrS Proposed sale
CHRISTOPHER DELOREFICE

Former Officer

Officer
9,366
182.46
US$1,708,886 		9,366 182.46 US$1,708,886
2026-02-18 2026-02-18 PrS Proposed sale
3.0
BERTRAM SCOTT

Director

Non-Executive Director
953
182.61
US$174,027 		953 182.61 US$174,027
2026-01-28 2026-01-26 S Sale
2.8
Feld Michael

EVP, CRO & Pres. Life Sciences

Officer
75 -0.5%
202.73
US$15,205 		75 -0.5% 202.73 US$15,205
2026-01-26 2026-01-26 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
75
201.79
US$15,134 		75 201.79 US$15,134
2026-01-16 2026-01-15 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
1,010 -7.7%
206.54
US$208,605 		1,010 -7.7% 206.54 US$208,605
2026-01-16 2026-01-15 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
600 -4.4%
209.00
US$125,400 		600 -4.4% 209.00 US$125,400
2026-01-15 2026-01-15 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
1,610
207.42
US$333,946 		1,610 207.42 US$333,946
2025-12-29 2025-12-26 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
74
196.12
US$14,513 		74 196.12 US$14,513
2025-12-29 2025-12-26 S Sale
2.8
Feld Michael

EVP, CRO & Pres. Life Sciences

Officer
74 -0.4%
196.08
US$14,510 		74 -0.4% 196.08 US$14,510
2025-12-17 2025-12-17 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
629
196.39
US$123,529 		629 196.39 US$123,529
2025-12-17 2025-12-17 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
629 -4.6%
196.03
US$123,303 		629 -4.6% 196.03 US$123,303
2025-12-02 2025-12-01 S Sale
2.8
Feld Michael

EVP, CRO & Pres. Life Sciences

Officer
75 -0.5%
193.36
US$14,502 		75 -0.5% 193.36 US$14,502
2025-12-01 2025-12-01 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
75
194.02
US$14,552 		75 194.02 US$14,552
2025-11-07 2025-11-07 PrS Proposed sale
3.0
BERTRAM SCOTT

Officer

Officer
217
176.58
US$38,318 		217 176.58 US$38,318
2025-11-07 2025-11-07 S Sale
3.0
SCOTT BERTRAM L
Non-Executive Director
217 -0.6%
176.58
US$38,318 		217 -0.6% 176.58 US$38,318
2025-10-28 2025-10-27 S Sale
2.8
Feld Michael

EVP & President, Life Sciences

Officer
57 -0.7%
186.01
US$10,603 		57 -0.7% 186.01 US$10,603
2025-10-27 2025-10-27 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
57
185.83
US$10,592 		57 185.83 US$10,592
2025-09-29 2025-09-26 S Sale
2.8
Feld Michael

EVP & President, Life Sciences

Officer
58 -0.7%
181.03
US$10,500 		58 -0.7% 181.03 US$10,500
2025-09-26 2025-09-26 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
58
180.59
US$10,474 		58 180.59 US$10,474
2025-09-11 2025-09-10 S Sale
3.5
Fraser Claire
Non-Executive Director
917 -4.0%
187.50
US$171,938 		917 -4.0% 187.50 US$171,938
2025-09-10 2025-09-10 PrS Proposed sale
3.5
Fraser Claire

Director

Non-Executive Director
917
187.42
US$171,862 		917 187.42 US$171,862
2025-08-26 2025-08-22 S Sale
2.8
Feld Michael

EVP & President, Life Sciences

Officer
57 -0.7%
197.99
US$11,285 		57 -0.7% 197.99 US$11,285
2025-08-22 2025-08-22 PrS Proposed sale
2.8
MICHAEL FELD

Officer

Officer
57
196.63
US$11,208 		57 196.63 US$11,208
2025-08-11 2025-08-11 B Purchase
3.5
HAYES GREGORY
Non-Executive Director
5,250 +659.5%
191.57
US$1,005,742 		5,250 +659.5% 191.57 US$1,005,742
2025-08-08 2025-08-08 PrS Proposed sale
3.5
Fraser Claire

Director

Non-Executive Director
863
192.21
US$165,880 		863 192.21 US$165,880
2025-08-08 2025-08-08 S Sale
3.5
Fraser Claire
Non-Executive Director
863 -3.6%
192.30
US$165,955 		863 -3.6% 192.30 US$165,955
2025-07-22 2025-07-18 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
1 -0.0%
181.50
US$182 		1 -0.0% 181.50 US$182
2025-07-22 2025-07-18 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
1,184 -19.5%
180.29
US$213,463 		1,184 -19.5% 180.29 US$213,463
2025-07-18 2025-07-18 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
1,185
180.90
US$214,366 		1,185 180.90 US$214,366
2025-06-02 2025-06-02 PrS Proposed sale
2.4
DAVID SHAN

Officer

Officer
1,166
172.59
US$201,240 		1,166 172.59 US$201,240
2025-06-02 2025-06-02 S Sale
2.4
Shan David

EVP and Chief ISC Officer

Officer
1,166 -20.3%
171.19
US$199,608 		1,166 -20.3% 171.19 US$199,608
2025-04-10 2025-04-09 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
479 -8.9%
197.28
US$94,497 		479 -8.9% 197.28 US$94,497
2025-04-09 2025-04-09 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
479
200.83
US$96,198 		479 200.83 US$96,198
2025-03-19 2025-03-18 S Sale
3.2
Byrd Richard

EVP & President Interventional

Officer
459 -6.2%
230.00
US$105,570 		459 -6.2% 230.00 US$105,570
2025-03-18 2025-03-18 PrS Proposed sale
3.2
RICHARD BYRD

Officer

Officer
459
227.83
US$104,574 		459 227.83 US$104,574
2025-03-13 2025-03-12 S Sale
3.2
Byrd Richard

EVP & President Interventional

Officer
1,940 -20.7%
224.91
US$436,325 		1,940 -20.7% 224.91 US$436,325
2025-03-12 2025-03-12 PrS Proposed sale
3.2
RICHARD BYRD

Officer

Officer
1,940
224.92
US$436,345 		1,940 224.92 US$436,345
2025-02-12 2025-02-12 PrS Proposed sale
3.0
BERTRAM SCOTT

Director

Non-Executive Director
700
227.99
US$159,593 		700 227.99 US$159,593
2025-02-12 2025-02-12 S Sale
3.0
SCOTT BERTRAM L
Non-Executive Director
700 -1.9%
227.99
US$159,593 		700 -1.9% 227.99 US$159,593
2025-02-10 2025-02-10 B Purchase
2.9
Henderson Jeffrey William
Non-Executive Director
1,500 +23.0%
233.62
US$350,430 		1,500 +23.0% 233.62 US$350,430
2025-01-22 2025-01-21 S Sale
3.1
Neal Shana Carol

EVP and Chief People Officer

Officer
787 -4.9%
240.00
US$188,880 		787 -4.9% 240.00 US$188,880
2025-01-22 2025-01-21 S Sale
2.4
Shan David

EVP and Chief ISC Officer

Officer
500 -8.0%
240.00
US$120,000 		500 -8.0% 240.00 US$120,000
2025-01-21 2025-01-21 PrS Proposed sale
3.1
SHANA NEAL

Officer

Officer
787
237.38
US$186,818 		787 237.38 US$186,818
2025-01-21 2025-01-21 PrS Proposed sale
2.4
DAVID SHAN

Officer

Officer
500
237.38
US$118,690 		500 237.38 US$118,690
2025-01-21 2025-01-17 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
597 -9.7%
236.51
US$141,196 		597 -9.7% 236.51 US$141,196
2025-01-17 2025-01-17 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
597
236.30
US$141,071 		597 236.30 US$141,071
2025-01-10 2025-01-07 S Sale
3.1
Neal Shana Carol

EVP and Chief People Officer

Officer
788 -4.6%
235.00
US$185,180 		788 -4.6% 235.00 US$185,180
2025-01-07 2025-01-07 PrS Proposed sale
3.1
SHANA NEAL

Officer

Officer
788
230.70
US$181,792 		788 230.70 US$181,792
Explore more

More insider trading research around Becton Dickinson and Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America
Insider trades in S&P 500